Hypermarcas (OTCMKTS:HYPMY) Shares Gap Down – Here’s What Happened

Hypermarcas (OTCMKTS:HYPMY)’s stock price gapped down before the market opened on Friday . The stock had previously closed at $4.27, but opened at $4.14. Hypermarcas shares last traded at $4.12, with a volume of 1,585 shares trading hands.

Wall Street Analysts Forecast Growth

Separately, Jefferies Financial Group upgraded shares of Hypermarcas to a “strong-buy” rating in a research note on Monday, July 20th. One research analyst has rated the stock with a Strong Buy rating and one has given a Hold rating to the company. According to MarketBeat, the stock presently has an average rating of “Buy”.

Hypermarcas Trading Up 0.7%

The company has a market capitalization of $2.90 billion, a price-to-earnings ratio of 8.24 and a beta of 0.70. The stock has a 50-day simple moving average of $4.10 and a 200-day simple moving average of $4.29.

Hypermarcas (OTCMKTS:HYPMY) last released its earnings results on Thursday, August 6th. The company reported $0.14 earnings per share for the quarter, topping the consensus estimate of $0.13 by $0.01. Hypermarcas had a net margin of 19.77% and a return on equity of 14.63%. On average, research analysts forecast that Hypermarcas will post 0.53 EPS for the current year.

About Hypermarcas

Hypermarcas SA is a Brazil-based consumer health and pharmaceutical company whose shares trade over the counter in the United States under the symbol HYPMY. Founded in the early 2000s and headquartered in Rio de Janeiro, the company operates as a holding group for a broad portfolio of branded products in the healthcare and personal care sectors.

Through its various subsidiaries, Hypermarcas develops, manufactures and markets prescription and over-the-counter medications, alongside personal care, baby care, home care and nutritional supplement products.